Tag: ASX: NSB
NeuroScientific begins cell therapy manufacturing transfer to Q-Gen
NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has commenced the transfer of its patented cell manufacturing process to Q-Gen Cell Therapeutics, a move the company says is a key step in advancing its clinical development and commercialisation plans.
Featured Article
Driving the future of smart energy: GridBeyond and ABB unveil new white paper on battery storage innovation
As industries adopt cleaner, more intelligent energy solutions, the ability to manage, store, and trade energy efficiently is increasingly vital to sustaining a competitive edge.
